Novo Nordisk spends big in France to expand obesity drug capacity
INSUBCONTINENT EXCLUSIVE:
CHARTRES (FRANCE) - Danish pharmaceutical giant Novo Nordisk on Thursday announced a major investment in a French production site to expand
capacity including for a blockbuster anti-obesity drug.
